Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

APELLIS PHARMACEUTICALS, INC.

(APLS)
  Report
Delayed Nasdaq  -  04:00 2022-09-30 pm EDT
68.30 USD   +4.42%
09/30Aao 2022 : Treatment of Geographic Atrophy Secondary to AMD with Pegcetacoplan: Two-Year Outcomes from the Randomized Phase 3 OAKS and DERBY Trials
PU
09/30Apellis Announces 24-Month Phase 3 Post Hoc Results Showing Treatment with Pegcetacoplan Led to Preservation of Function in High-Risk Areas of the Retina in Patients with Geographic Atrophy (GA) at AAO Annual Meeting
GL
09/30Apellis Announces 24-Month Phase 3 Post Hoc Results Showing Treatment with Pegcetacoplan Led to Preservation of Function in High-Risk Areas of the Retina in Patients with Geographic Atrophy (GA) at AAO Annual Meeting
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Analyst Recommendations on APELLIS PHARMACEUTICALS, INC.
09/12Wedbush Raises Price Target on Apellis Pharmaceuticals to $67 From $55, Sees Increased ..
MT
09/08Stifel Nicolaus Adjusts Price Target on Apellis Pharmaceuticals to $65 From $60, Keeps ..
MT
09/07B. Riley Downgrades IVERIC bio to Sell from Neutral After 'Disappointing' Data Which Re..
MT
08/25Analyst recommendations: Nvidia, Thermo Fisher Scientific, Danah..
MS
08/24Wedbush Adjusts Apellis Pharmaceuticals Price Target to $55 From $45, Maintains Neutral..
MT
08/09Credit Suisse Raises Apellis Pharmaceuticals' Price Target to $52 from $49, Updates Mod..
MT
08/09Raymond James Adjusts Price Target on Apellis Pharmaceuticals to $113 From $102, Reiter..
MT
08/09Goldman Sachs Adjusts Price Target on Apellis Pharmaceuticals to $102 From $91, Reitera..
MT
08/09Wedbush Lifts Price Target on Apellis Pharmaceuticals to $45 From $42, Maintains Neutra..
MT
07/20Citigroup Adjusts Price Target on Apellis Pharmaceuticals to $86 From $81, Reiterates B..
MT
07/19HC Wainwright Starts Apellis Pharmaceuticals at Buy With $75 Price Target
MT
07/14Wedbush Lifts Price Target on Apellis Pharmaceuticals to $42 From $40, Maintains Neutra..
MT
06/16Stifel Initiates Coverage of Apellis Pharmaceuticals With Buy Rating, $60 Price Target
MT
05/24Goldman Sachs Adjusts Apellis Pharmaceuticals' Price Target to $84 from $94, Keeps Buy ..
MT
05/20Credit Suisse Raises Apellis Pharmaceuticals' Price Target to $49 from $44, Maintains N..
MT
05/05Raymond James Adjusts Apellis Pharmaceuticals' Price Target to $102 from $114, Keeps St..
MT
05/05Credit Suisse Raises Apellis Pharmaceuticals' PT to $44 from $40, Says On Track to Subm..
MT
05/05Wedbush Lifts Apellis Pharmaceuticals' Price Target to $40 From $39, Maintains Neutral ..
MT
04/28Wedbush Lifts Price Target on Apellis Pharmaceuticals to $39 From $34, Maintains Neutra..
MT
04/22Oppenheimer Adjusts Apellis Pharmaceuticals Price Target to $68 From $65, Maintains Out..
MT
04/14Roth Capital Downgrades Apellis Pharmaceuticals to Sell From Neutral; Price Target is $..
MT
04/04JPMorgan Adjusts Apellis Pharmaceuticals Price Target to $69 From $66, Maintains Overwe..
MT
03/17Jefferies Raises Apellis Pharmaceuticals' Price Target to $79 From $74, Maintains Buy R..
MT
03/17JPMorgan Raises Price Target for Apellis Pharmaceuticals to $66 From $58, Maintains Ove..
MT
03/17Baird Adjusts Apellis Pharmaceuticals' Price Target to $90 From $83, Keeps Outperform R..
MT
03/01Raymond James Adjusts Apellis Pharmaceuticals' Price Target to $114 from $112, Maintain..
MT
02/14Credit Suisse Lifts Apellis Pharmaceuticals' Price Target to $40 from $38, Maintains Ne..
MT
01/25Wedbush Lifts Apellis Pharmaceuticals' Price Target to $34 From $28, Citing Empaveli La..
MT
01/11Raymond James Adjust Apellis Pharmaceuticals' Price Target to $112 from $116, Keeps Str..
MT
2021Wells Fargo Starts Apellis Pharmaceuticals at Overweight With $84 Price Target
MT
2021Roth Capital Cuts Apellis Pharmaceuticals to Neutral From Buy, Price Target to $40 From..
MT
2021Citigroup Adjusts Price Target on Apellis Pharmaceuticals to $72 From $65, Maintains Bu..
MT
2021Raymond James Adjusts Apellis Pharmaceuticals' Price Target to $116 From $102, Keeps St..
MT
2021Wedbush Cuts Apellis Pharmaceuticals' Price Target to $28 From $34, Citing 'Cash Constr..
MT
2021Apellis Pharmaceuticals : Wedbush Adjusts Price Target for Apell..
MT
2021Apellis Pharmaceuticals : Baird Adjusts Apellis Pharmaceuticals'..
MT
2021Apellis Pharmaceuticals : Goldman Sachs Adjusts Apellis Pharmace..
MT
2021Apellis Pharmaceuticals : Roth Capital Adjusts Apellis Pharmaceu..
MT
2021Apellis Pharmaceuticals : Oppenheimer Adjusts Apellis Pharmaceut..
MT
2021Apellis Pharmaceuticals : JPMorgan Adjusts Apellis Pharmaceutica..
MT
2021Apellis Pharmaceuticals : BMO Capital Adjusts Apellis Pharmaceut..
MT
2021Apellis Pharmaceuticals : Needham Adjusts Apellis Pharmaceutical..
MT
2021Apellis Pharmaceuticals : Wedbush Downgrades Apellis Pharmaceuti..
MT
2021Apellis Pharmaceuticals : Credit Suisse Lowers Apellis Pharmaceu..
MT
2021Apellis Pharmaceuticals : Wedbush Lifts Apellis Pharmaceuticals ..
MT
2021Apellis Pharmaceuticals : Jefferies Starts Apellis Pharmaceutica..
MT
2021Apellis Pharmaceuticals : Credit Suisse Raises Apellis Pharmaceu..
MT
2021Apellis Pharmaceuticals : Raymond James Adjusts Price Target on ..
MT
2021Apellis Pharmaceuticals : Wedbush Adjusts Apellis Pharmaceutical..
MT
2021Apellis Pharmaceuticals : BMO Capital Adjusts Apellis Pharmaceut..
MT
2021Apellis Pharmaceuticals : JPMorgan Adjusts Price Target on Apell..
MT
2021Apellis Pharmaceuticals : Cowen Adjusts Apellis Pharmaceuticals ..
MT
2021Apellis Pharmaceuticals : Needham Adjusts Price Target on Apelli..
MT
2021Apellis Pharmaceuticals : UBS Initiates Coverage on Apellis Phar..
MT
2021Apellis Pharmaceuticals : Goldman Sachs Adjusts Apellis Pharmace..
MT
2021Apellis Pharmaceuticals : BMO Capital Adjusts Price Target on Ap..
MT
2021Apellis Pharmaceuticals : JPMorgan Adjusts Price Target on Apell..
MT
2021Apellis Pharmaceuticals : Roth Capital Adjusts Price Target on A..
MT
2021Apellis Pharmaceuticals : Wedbush Adjusts Price Target on Apelli..
MT
2021Apellis Pharmaceuticals : Credit Suisse Raises Apellis Pharmaceu..
MT
2021Apellis Pharmaceuticals : Goldman Sachs Initiates Apellis Pharma..
MT
2021Apellis Pharmaceuticals : Credit Suisse Raises Apellis Pharmaceu..
MT
2021Apellis Pharmaceuticals : Wedbush Adjusts Price Target on Apelli..
MT
2021Apellis Pharmaceuticals : Credit Suisse Adjusts Apellis Pharmace..
MT
2021Apellis Pharmaceuticals : Raymond James Adjusts Apellis Pharmace..
MT
2021Apellis Pharmaceuticals : Stifel Adjusts Apellis Pharmaceuticals..
MT
2020Apellis Pharmaceuticals : Roth Capital Adjusts Apellis Pharmaceu..
MT
2020Apellis Pharmaceuticals : BMO Capital Adjusts Apellis Pharmaceut..
MT
2020Apellis Pharmaceuticals : Citigroup Adjusts Price Target on Apel..
MT
2020Apellis Pharmaceuticals : Needham Starts Apellis Pharmaceuticals..
MT
2020Apellis Pharmaceuticals : Wedbush Adjusts Price Target on Apelli..
MT
2020Apellis Pharmaceuticals : Wedbush Adjusts Price Target on Apelli..
MT
Upcoming event on APELLIS PHARMACEUTICALS, INC.